EP1082460A4 - A novel method of diagnosing, monitoring, and staging prostate cancer - Google Patents

A novel method of diagnosing, monitoring, and staging prostate cancer

Info

Publication number
EP1082460A4
EP1082460A4 EP99921946A EP99921946A EP1082460A4 EP 1082460 A4 EP1082460 A4 EP 1082460A4 EP 99921946 A EP99921946 A EP 99921946A EP 99921946 A EP99921946 A EP 99921946A EP 1082460 A4 EP1082460 A4 EP 1082460A4
Authority
EP
European Patent Office
Prior art keywords
diagnosing
monitoring
prostate cancer
novel method
staging prostate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99921946A
Other languages
German (de)
French (fr)
Other versions
EP1082460A1 (en
Inventor
Shujath Ali
Susana Salceda
Yongming Sun
Robert Cafferkey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Priority to EP05019760A priority Critical patent/EP1621639A3/en
Publication of EP1082460A1 publication Critical patent/EP1082460A1/en
Publication of EP1082460A4 publication Critical patent/EP1082460A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP99921946A 1998-05-21 1999-05-12 A novel method of diagnosing, monitoring, and staging prostate cancer Withdrawn EP1082460A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05019760A EP1621639A3 (en) 1998-05-21 1999-05-12 A novel method of diagnosing, monitoring and staging prostate cancer

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8626598P 1998-05-21 1998-05-21
US86265P 1998-05-21
PCT/US1999/010548 WO1999060162A1 (en) 1998-05-21 1999-05-12 A novel method of diagnosing, monitoring, and staging prostate cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP05019760A Division EP1621639A3 (en) 1998-05-21 1999-05-12 A novel method of diagnosing, monitoring and staging prostate cancer

Publications (2)

Publication Number Publication Date
EP1082460A1 EP1082460A1 (en) 2001-03-14
EP1082460A4 true EP1082460A4 (en) 2003-02-12

Family

ID=22197399

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99921946A Withdrawn EP1082460A4 (en) 1998-05-21 1999-05-12 A novel method of diagnosing, monitoring, and staging prostate cancer

Country Status (4)

Country Link
EP (1) EP1082460A4 (en)
JP (1) JP3677210B2 (en)
CA (1) CA2328377A1 (en)
WO (1) WO1999060162A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US20020004206A1 (en) * 1999-04-09 2002-01-10 Berger Barry M. Methods of screening for disease
US20020048777A1 (en) 1999-12-06 2002-04-25 Shujath Ali Method of diagnosing monitoring, staging, imaging and treating prostate cancer
AU2002236579A1 (en) * 2000-11-06 2002-05-21 Diadexus, Inc. Compositions and methods relating to prostate specific genes and proteins
AU2002235164A1 (en) * 2000-11-06 2002-05-21 Diadexus, Inc. Compositions and methods relating to prostate specific genes and proteins
AU2002239412A1 (en) * 2000-11-21 2002-06-03 Diadexus, Inc. Compositions and methods relating to prostate specific genes and proteins
US20020127237A1 (en) * 2000-11-21 2002-09-12 Susana Salceda Compositions and methods relating to prostate specific genes and proteins
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999000498A1 (en) * 1997-06-27 1999-01-07 Human Genome Sciences, Inc. Human nk-3 related prostate specific gene-1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69332642T2 (en) * 1992-10-29 2003-10-02 Thomas Jefferson University, Philadelphia METHODS FOR DETECTING MICROMETASAS IN PROSTATE CANCER

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999000498A1 (en) * 1997-06-27 1999-01-07 Human Genome Sciences, Inc. Human nk-3 related prostate specific gene-1

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 15 October 2002 (2002-10-15), XP002223221, retrieved from EMBL Database accession no. NM_006167 *
DATABASE EMBL [online] 17 December 1996 (1996-12-17), XP002084746, retrieved from EMBL Database accession no. U80669 *
HE W W ET AL: "a novel human prostate-specific androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 43, no. 1, 1 July 1997 (1997-07-01), pages 69 - 77, XP002084749, ISSN: 0888-7543 *
LOPEZ-OTIN CARLOS ET AL: "Breast and prostate cancer: An analysis of common epidemiological, genetic, and biochemical features.", ENDOCRINE REVIEWS, vol. 19, no. 4, August 1998 (1998-08-01), pages 365 - 396, XP002220464, ISSN: 0163-769X *
OLSSON C A ET AL: "REVERSE TRANSCRIPTASE-POLYMER CHAIN REACTION ASSAYS FOR PROSTATE CANCER", UROLOGIC CLINICS OF NORTH AMERICA, SAUNDERS CO., LONDON, GB, vol. 24, no. 2, May 1997 (1997-05-01), XP002923009, ISSN: 0094-0143 *
PRESCOTT J L ET AL: "Isolation and androgen regulation of the human homeobox cDNA, NKX3.1", PROSTATE, WILEY-LISS, NEW YORK, NY, US, vol. 35, no. 1, U80669, 1 April 1998 (1998-04-01), pages 71 - 80, XP002084750, ISSN: 0270-4137, Retrieved from the Internet <URL:EMBL> *
See also references of WO9960162A1 *
VOELLER H J ET AL: "Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 57, 15 October 1997 (1997-10-15), pages 4455 - 4459, XP002084751, ISSN: 0008-5472 *

Also Published As

Publication number Publication date
CA2328377A1 (en) 1999-11-25
EP1082460A1 (en) 2001-03-14
WO1999060162A1 (en) 1999-11-25
JP3677210B2 (en) 2005-07-27
JP2002515263A (en) 2002-05-28

Similar Documents

Publication Publication Date Title
EP1082459A4 (en) A novel method of diagnosing, monitoring, and staging lung cancer
EP1239874A4 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EP1105528A4 (en) A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
AU6688598A (en) Method for diagnosing and staging prostate cancer
MXPA01008794A (en) Method of diagnosing and monitoring malignant breast carcinomas.
EP0975803A4 (en) Method for assessing prostate cancer
GB2347445B (en) Drilling method
GB2340152B (en) Multiple string completion apparatus and method
GB9904101D0 (en) Subsurface structure identification method
HK1024571A1 (en) Iron core assembly and method for producing the same
GB2318641B (en) Measuring borehole geometry
GB2388138B (en) Assembly for and method of performing a well operation
EP1131095A4 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
AU2001250932A1 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating prostate cancer
EP1267934A4 (en) A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
GB9701612D0 (en) Downhole production well instrumentation
EP1082460A4 (en) A novel method of diagnosing, monitoring, and staging prostate cancer
EP1104486A4 (en) A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer
EP1107798A4 (en) A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
GB9822767D0 (en) Drilling method
EP1126877A4 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
AU2001271621A1 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
GB9825583D0 (en) Pipe lining method
GB0111797D0 (en) Rotating casing assembly and method
EP1128848A4 (en) A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001221

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DIADEXUS, INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DIADEXUS, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7G 01N 33/567 B

Ipc: 7G 01N 33/574 B

Ipc: 7G 01N 33/53 B

Ipc: 7C 12Q 1/68 A

A4 Supplementary search report drawn up and despatched

Effective date: 20030103

17Q First examination report despatched

Effective date: 20040813

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20051010